PubRank

H P Dienes

Author PubWeight™ 144.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis 1981 4.15
2 Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997 3.52
3 Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol 2001 2.20
4 Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood 1994 2.16
5 Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001 1.85
6 Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1990 1.83
7 Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 1999 1.79
8 Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer 1996 1.76
9 TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999 1.69
10 Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 1995 1.68
11 Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 1997 1.64
12 Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology 1990 1.57
13 [Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe 2004 1.53
14 p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol 2001 1.42
15 Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992 1.27
16 Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999 1.25
17 Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat 2001 1.23
18 Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. AJR Am J Roentgenol 1999 1.23
19 Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 1994 1.21
20 Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. J Hepatol 1987 1.17
21 Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer 2000 1.16
22 Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996 1.16
23 Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol 1999 1.15
24 Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 2001 1.14
25 Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med 1997 1.13
26 Histologic observations in human hepatitis non-A, non-B. Hepatology 1982 1.13
27 Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology 1996 1.12
28 Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994 1.10
29 Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 2000 1.08
30 Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology 2002 1.08
31 Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues. Mol Pathol 2003 1.07
32 Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res 1997 1.05
33 Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 1997 1.04
34 Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer 1998 1.01
35 Isolation and characterization of a 60-70-kD plasma membrane glycoprotein involved in the contact-dependent inhibition of growth. J Cell Biol 1990 1.00
36 Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection. Mult Scler 2007 1.00
37 Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol 1997 0.98
38 Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 2001 0.96
39 Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms. Cancer 1998 0.96
40 Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. Histol Histopathol 2002 0.95
41 Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. Clin Exp Immunol 1984 0.95
42 Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol 1988 0.95
43 Involvement of actin-containing microfilaments in HSV-induced cytopathology and the influence of inhibitors of glycosylation. Arch Virol 1986 0.94
44 Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol 1998 0.94
45 Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer 2004 0.94
46 Parenchymal and nonparenchymal liver cells and their interaction in the local immune response. Z Gastroenterol 1995 0.94
47 Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients. Cancer 2000 0.94
48 Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks. J Viral Hepat 2012 0.94
49 Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. Liver 1996 0.93
50 Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues. Cancer Res 1985 0.92
51 The role of autoimmunity in hepatitis C infection. J Hepatol 1995 0.91
52 [Growth factors in liver regeneration and hepatocarcinogenesis]. Verh Dtsch Ges Pathol 1995 0.91
53 [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines]. Pathologe 2010 0.90
54 Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation. Tumour Biol 2000 0.90
55 Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology 2003 0.90
56 In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys. Med Microbiol Immunol 1993 0.90
57 Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin Immunol Immunopathol 1994 0.89
58 [Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet)]. Pathologe 2004 0.89
59 Binding properties of mechanically and enzymatically isolated hepatocytes for IgG and C3. Liver 1983 0.89
60 Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener's granulomatosis. Kidney Int 2000 0.89
61 Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology 1998 0.88
62 Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S- and S-encoded viral surface antigens. Hepatology 1991 0.88
63 [Autopsy records in Cologne from 1914 to 1960: changes in diseases, society and institution]. Pathologe 2008 0.88
64 Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol 2008 0.88
65 Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: Sialosyl-Lewis(a), Sialosyl-Lewis(x) and sialosyl-Tn. Tumour Biol 1998 0.88
66 Membranous nephropathy from exposure to mercury in the fluorescent-tube-recycling industry. Nephrol Dial Transplant 2001 0.88
67 Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial. Eur J Endocrinol 1998 0.88
68 Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases. Z Gastroenterol 1997 0.88
69 Hepatic steatosis in organ donors: disparity between surgery and histology? Transplant Proc 2009 0.88
70 Oval cell lines OC/CDE 6 and OC/CDE 22 give rise to cholangio-cellular and undifferentiated carcinomas after transformation. Lab Invest 1994 0.87
71 The role of Ito cells in the biosynthesis of HGF-SF in the liver. EXS 1993 0.87
72 Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody. Cancer Res 1987 0.87
73 Lymphocytes from hepatic inflammatory infiltrate kill rat hepatocytes in primary culture. Comparison with peripheral blood lymphocytes. Virchows Arch B Cell Pathol Incl Mol Pathol 1990 0.86
74 Therapy of prednisone-refractory collagenous colitis with budesonide. Int J Colorectal Dis 1999 0.86
75 Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. Exp Cell Res 1993 0.86
76 Current pathogenetic and molecular concepts in viral liver carcinogenesis. Virchows Arch B Cell Pathol Incl Mol Pathol 1993 0.86
77 Randomized, double blind, placebo-controlled trial of low dose iodide in endemic goiter. J Clin Endocrinol Metab 1997 0.86
78 Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991 0.86
79 [Liver metastases: incidence and histogenesis]. Z Gastroenterol 2005 0.85
80 Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 1995 0.85
81 Electron microscopic observations on primary hepatocyte cultures infected with herpes simplex virus types I and II. Virchows Arch B Cell Pathol Incl Mol Pathol 1984 0.85
82 Signet ring stomach cancer: morphological characterization and antigenic profile of a newly established cell line (Mz-Sto-1). Eur J Cancer Clin Oncol 1987 0.85
83 Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z Gastroenterol 1995 0.84
84 Microsomal and cytosolic epoxide hydrolases, the peroxisomal fatty acid beta-oxidation system and catalase. Activities, distribution and induction in rat liver parenchymal and non-parenchymal cells. Eur J Biochem 1988 0.84
85 Hepatocellular carcinoma after thorotrast exposure: establishment of a new cell line (Mz-Hep-1). Hepatology 1985 0.84
86 Expression of the 60 kDa heat shock protein in normal and inflamed liver. J Hepatol 1993 0.84
87 Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 1991 0.84
88 Changes in the extracellular matrix of the vein wall--the cause of primary varicosis? Vasa 2000 0.84
89 Alterations of the extracellular matrix of venous walls in varicous veins. Vasa 1999 0.84
90 Heterogeneity of squamous cell carcinomas of the head and neck--analysis of tumor biologic factors and proliferation rates. Laryngoscope 1996 0.84
91 Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1. Histol Histopathol 1999 0.83
92 Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer. Oncology 2001 0.83
93 Rapid immunohistochemical detection of tumor cells in gastric carcinoma. Oncol Rep 2006 0.83
94 Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis. Virchows Arch 1996 0.83
95 Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode. J Hepatol 1999 0.83
96 A common epithelial cell surface antigen (EPM-1) on gastrointestinal tumors and in human sera. Cancer Res 1987 0.82
97 [Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?]. Dtsch Med Wochenschr 2005 0.82
98 Infection of murine hepatocyte cultures by herpes simplex virus (HSV) 1 and 2. Liver 1984 0.82
99 Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas. Anticancer Res 2001 0.82
100 Sinusoidal endothelial cells from guinea pig liver synthesize and secrete cellular fibronectin in vitro. Hepatology 1987 0.82
101 [Highly differentiated hepatocellular tumors. Concepts, criteria, and differential diagnosis]. Pathologe 2001 0.82
102 Liver membrane autoantibodies in chronic active hepatitis. Studies on mechanically and enzymatically isolated rabbit hepatocytes. J Hepatol 1987 0.81
103 Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. Liver 1996 0.81
104 The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells. Hepatology 1997 0.81
105 [Pleomorphic adenoma (mixed tumor) of the external auditory canal. Differential diagnosis of the tumors of the ceruminal glands]. Pathologe 1999 0.81
106 Comparative quantitative analysis of macrophage populations defined by CD68 and carbohydrate antigens in normal and pathologically altered human liver tissue. Anal Cell Pathol 1998 0.81
107 Expression of a novel T-cell activation antigen on bile canaliculi. N Engl J Med 1986 0.81
108 Microtubules and intermediate filaments of herpes simplex virus infected cells. Arch Virol 1987 0.81
109 Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer. Histopathology 2007 0.81
110 Establishment and characterization of a nontumorigenic cell line derived from a human hepatocellular adenoma expressing hepatocyte-specific markers. Exp Cell Res 1997 0.80
111 Correlation of virus replication, cytokine (TNF-alpha and IL-1) producing cells, neuronal necrosis and inflammation after intranasal infection of mice with herpes simplex virus strains of different virulence. Arch Virol 1995 0.80
112 Uptake of bead-adsorbed versus soluble antigen by bone marrow derived dendritic cells triggers their activation and increases their antigen presentation capacity. Adv Exp Med Biol 1995 0.80
113 [Diagnosis, progression and therapy of hepatitis C virus infection as well as viral infection in children and adolescents--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network]. Z Gastroenterol 2004 0.79
114 Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. J Hepatol 1986 0.79
115 [Current aspects of liver allograft pathology]. Pathologe 2011 0.79
116 [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)]. Dtsch Med Wochenschr 2001 0.79
117 Apoptosis and expression of bcl-2 protein are inverse factors influencing tumour cell turnover in primary carcinoid tumours of the lung. Histopathology 1998 0.79
118 Loss of surface fibronectin after infection of cultured cells by HSV-1 and 2. Arch Virol 1985 0.79
119 Role of the Ha-ras gene in the malignant transformation of rat liver oval cells. Int J Cancer 1997 0.79
120 The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha. J Hepatol 1996 0.79
121 [Adenocarcinoid of the appendix vermiformis]. Pathologe 2005 0.78
122 Herpes simplex virus type 1 and 2 in the adrenal glands: replication and histopathology. Arch Virol 1986 0.78
123 Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro. J Hepatol 1987 0.78
124 Expression of Ia-antigens on guinea pig Kupffer cells. Studies with monoclonal antibodies. J Hepatol 1986 0.78
125 Tenascin expression in gastric cancer with special emphasis on the WHO-, Lauren-, and Goseki-classifications. Int J Mol Med 1999 0.78
126 Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha. Z Gastroenterol 1997 0.78
127 [Epithelial-mesenchymal transition of biliary epithelial cells in advanced liver fibrosis]. Verh Dtsch Ges Pathol 2007 0.78
128 Application of immunoelectron microscopy for identification of T lymphocyte subsets and HLA DR antigen positive cells in tissue. J Histochem Cytochem 1984 0.78
129 Soft tissue osteoma: tumour entity or reactive lesion? Paraarticular soft tissue osteoma of the hip. Histopathology 2004 0.78
130 [Malignant lymphomas of the liver: new diagnostic algorithms]. Pathologe 2006 0.78
131 De novo expression of nonhepatocellular cytokeratins in Mallory body formation. Virchows Arch 1998 0.77
132 Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: a contribution to the self-limitation of cellular immune reactions in reactive arthritis? J Infect Dis 1997 0.77
133 Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and 2. II. Histopathological, immunohistochemical and in situ hybridization studies. Arch Virol 1991 0.77
134 Lewis(y) antigen (CD174) and apoptosis in gastric and colorectal carcinomas: correlations with clinical and prognostic parameters. Histol Histopathol 2006 0.77
135 Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 1991 0.77
136 Crystalloid lysozyme inclusions in Paneth cells of vitamin A-deficient rats. Cell Tissue Res 1990 0.77
137 [The central odontogenic fibroma. A rare tumor]. Pathologe 2002 0.77
138 Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Z Gastroenterol 1994 0.77
139 [Biopsy diagnosis of chronic hepatitis]. Z Gastroenterol 2004 0.77
140 Analysis of microsatellite instability in colorectal carcinoma by microfluidic-based chip electrophoresis. J Clin Pathol 2008 0.77
141 [HPV-associated tonsillar cancer. An update]. HNO 2004 0.77
142 Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas. Int J Oncol 2001 0.77
143 Studies for estimating the biologic behavior and prognosis of paragangliomas in the head and neck. Skull Base Surg 1995 0.77
144 [Immunohistologic findings in paragangliomas in the area of the head and neck]. Laryngol Rhinol Otol (Stuttg) 1988 0.77
145 [Clear cell tumor of the lung]. Pathologe 2005 0.77
146 [Morphology of drug induced liver damage]. Pathologe 2006 0.76
147 Long-term follow-up of patients with chronic hepatitis B after interferon treatment. Z Gastroenterol 1996 0.76
148 Nodular nonsuppurative panniculitis in association with primary biliary cirrhosis and Hashimoto's thyroiditis. Z Rheumatol 1996 0.76
149 Intracellular accumulation of incompletely processed transforming growth factor-alpha polypeptides in ground glass hepatocytes of chronic hepatitis B virus infection. J Hepatol 1996 0.76
150 Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis. Anticancer Res 2001 0.76
151 Acute exacerbation of overlapping autoimmune liver disease with development of giant cell hepatitis after 14 years' disease duration. J Intern Med 1998 0.76
152 Is the urokinase-type plasminogen activator system a reliable prognostic factor in gastric cancer? Int J Biol Markers 2006 0.76
153 Transmission of hepatitis-B-virus by pleural effusion containing Dane particles. Hepatogastroenterology 1981 0.76
154 [Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection]. Z Gastroenterol 1995 0.76
155 [Simultaneous inoculation of hepatitis B virus and non-A non-B agents on a chimpanzee: histopathology in relation to electron microscopic and immunologic findings]. Verh Dtsch Ges Pathol 1981 0.75
156 [Liver biopsy in chronic hepatitis C. Histopathology, molecular diagnostic analysis, and implications for therapeutic management]. Pathologe 2001 0.75
157 [Lymph node dissection, stage migration and perioperative risk in rectal carcinoma]. Chirurg 1996 0.75
158 Fine-needle biopsy of parathyroid adenomas. Klin Wochenschr 1986 0.75
159 [Comment on the consensus report, "Treatment of chronic B/D viral hepatitis and acute and chronic C virus hepatitis"]. Z Gastroenterol 1998 0.75
160 [Glucagon-secreting malignant neuroendocrine tumor of the pancreas]. Med Klin (Munich) 2000 0.75
161 Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features. Digestion 1995 0.75
162 HCV-associated cryoglobulinaemia presenting with vasculitis, hepatitis, and glomerulonephritis - a therapeutic dilemma. Nephrol Dial Transplant 1996 0.75
163 [Acute fatty liver of pregnancy. A case report of the differential diagnosis of pregnancy-associated liver diseases]. Z Gastroenterol 1986 0.75
164 Acute hepatotoxicity of the polycyclic musk 7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphtaline (AHTN). Toxicol Lett 1999 0.75
165 Induction of early murine cytomegalovirus infection by different reporter gene-associated recombinant viruses. J Viral Hepat 2006 0.75
166 HSV hepatitis in the mouse: a light and electron microscopic study with immunohistology and in situ hybridization. Virchows Arch B Cell Pathol Incl Mol Pathol 1989 0.75
167 Analysis of liver-specific protein LSP using murine monoclonal antibodies. Eur J Clin Invest 1987 0.75
168 Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment. Hepatogastroenterology 1995 0.75
169 Ha-rasVal12 but not p53Ser247 leads to a significant neoplastic transformation rate of the putative rat liver stem cells (oval cell). Carcinogenesis 1996 0.75
170 Long-term follow-up of patients with chronic hepatitis C after interferon-alpha treatment. Digestion 1997 0.75
171 Organ specificity of LSP. Gastroenterology 1985 0.75
172 [Elevation of liver enzymes in a patient with chronic hepatitis B during alpha-interferon treatment: what is it all about?]. MMW Fortschr Med 2009 0.75
173 [Acute interstitial nephritis following piperacillin]. Klin Wochenschr 1989 0.75
174 Antigen-specific suppression of the experimental immune complex glomerulonephritis in rabbits by means of highly hot labelled antigen. Allergol Immunopathol (Madr) 1985 0.75
175 Cystic medical necrosis of the internal thoracic artery. Scand J Thorac Cardiovasc Surg 1996 0.75
176 An ovalbumin peptide-specific cytotoxic T cell clone with antigen self-presentation capacity uses two distinct mechanisms to kill target cells. Cell Immunol 1993 0.75
177 Hepatitis A-like non-A, non-B hepatitis: light and electron microscopic observations of three cases. Virchows Arch A Pathol Anat Histopathol 1986 0.75
178 Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha. Hepatology 1994 0.75
179 Cellular cytotoxicity against autologous hepatocytes in children with different forms of chronic hepatitis B. Eur J Pediatr 1990 0.75
180 [Morphologic findings in experimental non-A, non-B hepatitis]. Leber Magen Darm 1984 0.75
181 Unusual intranuclear inclusions in malignant fibrous histiocytoma: presence in primary tumor, metastases, and xenografts. Ultrastruct Pathol 1982 0.75
182 [Adenocarcinoma of the stomach with heterotopic ossification. Case report and discussion of the pathogenesis]. Pathologe 2002 0.75
183 Veno-occlusive disease of the liver in Hodgkin's disease prior to and resolution following chemotherapy. J Hepatol 1995 0.75
184 Postoperative fulminant varicella zoster virus hepatitis with fatal outcome: a case report. Z Gastroenterol 2008 0.75
185 [The risk of endocrine activation in interventional procedures on paraganglioma of the head and neck]. Radiologe 1988 0.75
186 [Immunohistological demonstration of alpha-1-fetoprotein (AFP) in human testicular tumors]. Verh Dtsch Ges Pathol 1978 0.75
187 [Inflammatory diseases of the vessels. Clinical aspects, immunopathology, characteristic features of therapy (author's transl)]. MMW Munch Med Wochenschr 1977 0.75
188 Characterization of circulating immune complexes in chronic non-A, non-B hepatitis. Digestion 1983 0.75
189 [Diagnostic relevance of lymph node size after 2-field lymph node excision in esophagus carcinomas]. Langenbecks Arch Chir Suppl Kongressbd 1998 0.75
190 [Deposition of keinoid fibers in gastrointestinal stromal tumors of the small intestine. Report of two cases and review of the literature]. Pathologe 2002 0.75
191 [Polyps of the sigmoid and rectum following ureterosigmoidostomy]. Z Gastroenterol 1980 0.75
192 [Highly differentiated squamous epithelial carcinoma as a late complication of post-traumatic osteomyelitis]. Pathologe 1999 0.75
193 [Unusual coincidence of partially active endocrine tumors]. Chirurg 1998 0.75
194 [Merkel cell carcinoma: an endocrine differentiated tumor in the head-neck area]. Laryngorhinootologie 1991 0.75
195 Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis. Eur J Pediatr 1992 0.75
196 [Immunohistological demonstration of serum proteins in formalin-fixed and native tissue--comparative studies in experimental glomerulonephritis in rats]. Verh Dtsch Ges Pathol 1978 0.75
197 [Coexpression of hepatocyte growth factor-scatter factor (HGF-SF) and HGF-SF receptors (c-met proto-oncogene) in mammalian brain]. Verh Dtsch Ges Pathol 1994 0.75
198 [Histopathology in liver transplantation]. Pathologe 2008 0.75
199 [Chronic active hepatitis: recurrence after long-term immunosuppressive therapy in spite of normal liver histology]. Z Gastroenterol 1983 0.75
200 Crystalloid lysozyme inclusions in Paneth cells of vitamin A-deficient rats. Ann N Y Acad Sci 1992 0.75
201 Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection. Clin Investig 1994 0.75
202 Prevention of experimental immune complex glomerulonephritis by specific inactivation of immunoreactive cells. Allergol Immunopathol (Madr) 1985 0.75
203 Lymphocyte mediated cell lysis. Virchows Arch B Cell Pathol Incl Mol Pathol 1989 0.75
204 [Goodpasture syndrome: treatment initiation with plasmapheresis before histologic diagnostic verification]. Pneumologie 1996 0.75
205 [Primary infection with Epstein-Barr virus in a 77-year-old patient with B symptoms and hepatitis -- a case report]. Z Gastroenterol 2006 0.75
206 A critical function of USF in HGF gene regulation mediated by a multiconsensus region. Biochem Biophys Res Commun 2002 0.75
207 [Myelolipoma of the adrenal gland]. Rontgenblatter 1984 0.75
208 Characterization of primary biliary cirrhosis (PBC) specific mitochondrial determinants by immunoblotting. Dtsch Z Verdau Stoffwechselkr 1987 0.75
209 [Diagnosis and differential diagnosis of hepatocellular carcinoma]. Pathologe 2006 0.75
210 [Primary cholangiocarcinoma in a case of Caroli's disease: case report and literature review]. Pathologe 2006 0.75
211 [Diseases of the liver and bile ducts in AIDS]. Z Gastroenterol Verh 1989 0.75
212 A monoclonal antibody directed against an organ-specific liver cell membrane antigen in rabbits. J Immunol Methods 1984 0.75
213 Virus-like particles in a case of acute hepatitis with human GB virus-C viraemia. Eur J Gastroenterol Hepatol 2001 0.75
214 Development of rat DC by in vitro culture of bone marrow cells. Adv Exp Med Biol 1995 0.75
215 [Delta infection in HBsAg carriers]. Z Gastroenterol 1984 0.75
216 Detection of mitochondrial antibodies directed against the primary biliary cirrhosis (M2) antigen by an enzyme-linked immunosorbent assay (ELISA). J Immunol Methods 1983 0.75
217 Spontaneous and antibody-dependent cellular immune reactions to ethanol-altered hepatoma cells. Liver 1987 0.75
218 Simultaneous infection with non-A, non-B and B viruses in a patient exhibiting different histologic patterns of acute hepatitis. Liver 1983 0.75